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Abstract  
 
The  hypoglycemic effects of hexane, chloroform and methanol  extracts from fruits of Ferocactus latispinus and Ferocactus histrix  were  
evaluated  by oral administration to normoglucemic and streptozotocin-induced severe diabetic rats  (SD). The anti-diabetic effect was examined by  blood 
glucose, triglycerides, lipid peroxidation, total cholesterol levels in the serum, glycogen content of liver and skeletal muscles,  superoxide dismutase (SOD) 
catalase (CAT), glutathione reductase (GR) and glutathione peroxidase (GSHPx) levels. The most active extracts were obtained with chloroform.  Chloroform  
extracts from F.  latispinus and F. histrix  increased activities of SOD, GR, GSHPx and CAT, hepatic glycogen content, glucose-6-phosphatase (G6Pase) and 
the  plasma insulin levels. They also, decreased glucokinase (GK) and TBAR (thiobarbituric acid assay). Of the two plants studied F.  latispinus showed 
better  antihyperglycemic and antihyperlipidemic effects that F. histrix.  In conclusion F.  latispinus and F. histrix  possesses significant antihyperglycemic 
properties after 4 h after a single oral dose. It can also improve hyperlipidemia and hypoinsulinemia in streptozotocin-induced diabetic. These results 
demonstrated that F.  latispinus and F. histrix typically used as a health food, has strong antidiabetic effects in vivo, thus, it may have beneficial properties in 
the prevention of diabetes.  
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Resumen 
 
Los efectos hipoglucemiantes de  extractos obtenidos con hexano, cloroformo y metanol a partir de frutos de Ferocactus latispinus y Ferocactus 
histrix fueron evaluados por la administración oral a ratas normales  y con diabetes severa (SD)  inducida por estreptozotocina. Los extractos más activos 
fueron obtenidos con cloroformo el cuál incrementa  los niveles de SOD, GR, GSHPx y el CAT, el contenido de glucógeno hepático, la glucosa-6-fosfatasa 
(G6Pase) y los niveles de insulina plasmática. También producen  disminución de la glucoquinasa (GK) y TBARS. De las dos plantas estudiadas la F. 
latispinus presento mayor actividad antihiperglicemiante y antihiperlipidémicos que la  F. histrix. En conclusión F. latispinus y F. histrix pueden mejorar la 
hiperlipidemia y la hipoinsulinemia en animales diabéticos inducida por estreptozotocina.  Estos resultados demostraron que F. latispinus y F. histrix 
utilizadas  normalmente como un alimento saludable, tiene fuertes efectos antidiabéticos in vivo, por lo tanto, pueden tener propiedades beneficiosas en la 
prevención de la diabetes. 
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INTRODUCTION 
Hyperglycemia and hyperlipidemia are two important 
characteristics of type 2 diabetes, an endocrine 
disorder based disease. Recently, attention has been 
focused on the relationship between reactive oxygen 
species (ROS) and several disorders including aging, 
various inflammatory diseases, carcinogenesis, 
neurodegenerative diseases, and diabetes. In fact, 
diabetes is usually accompanied by increased 
production of ROS and impaired antioxidant defense, 
indicating a central contribution of ROS to the onset, 
progression, and pathological consequences of 
diabetes (Venkatesh et al., 2010). There is 
considerable evidence that chronic hyperglycemia is 
the proximate cause of  retinopathy, kidney failure, 
neuropathies, and macrovascular diseases in diabetes. 
In addition, it has been demonstrated that β cells are 
particularly susceptible to oxidative damage. 
Therefore, as hyperglycemia worsens, β cells steadily 
deteriorate, secrete less insulin, and participate in a 
downward spiral of loss of pancreatic functions. 
Diabetes is a major risk factor for premature 
atherosclerosis, and oxidative stress plays an important 
role since diabetic monocytes produce increased 
superoxide anion (O2
-
). Hyperglycemia may  lead to 
increased generation of free radicals via multiple 
mechanisms (Coskun et al.,  2005). The chronic 
presence of high glucose levels enhances the 
production of reactive oxygen species (ROS) from 
protein glycation and glucose autoxidation, which in 
turn catalyze lipid peroxidation. Accordingly, 
disturbances of antioxidant defense systems in 
diabetes have been reported; alteration in antioxidant 
enzymes, impaired   gluthathion metabolism, and 
decreased ascorbic acid levels. Some studies on 
diabetes reported a significant increase in the products 
of both plasma and tissue lipid peroxidation compared 
with control (Fridlyand and Philipson, 2005). These 
findings resulted in new approaches to the treatment of 
diabetic patients, and the relevant studies focus on the 
support of antioxidant systems.  Insulin deficiency 
stimulates lipolysis in the adipose tissue, and gives rise 
to hyperlipidemia and fatty liver. Accordingly, 
although diabetes is characterized as a disease of 
carbohydrate metabolism, abnormalities of lipid and 
lipoprotein metabolism are commonly observed. Many 
natural products and medicinal plants have been 
shown to significantly reduce oxidative stress and 
increase the antioxidant endogenous system, which 
represent an important property of plant medicines 
used for the treatment of several diseases including 
diabetes (McCune   and   Johns,  2002). 
Ferocactus are plants widely distributed in several 
regions of Central Mexico  and popularly known as 
'biznaga' or ' Lengua del demonio'. The fruits of the 
plant are edible and commonly sold in local markets.  
The plant have  ball-shaped and is consumed as 
"acitron" which is crystallized  biznaga with sugar. In 
Mexico it has been used with medicinal purposes since 
pre-Hispanic times (Andrade-Cetto and Heinrich, 
2005). After going through the literature available, it 
seems that no phytochemical characterization and 
experimental work has been carried out to verify the 
claims of such anti-diabetic activity. The current 
investigation is an attempt to study the hypoglycemic 
effect of fruit extracts on normal and streptozocin 
induced diabetic,  are known as an insulin-deficiency 
model.  
 
Lista de abreviaciones: STZ- estreptozotocina; 
G6Pase-Glucose-6-phosphatase; GK-glucokinase; 
NADPH-β-nicotinamide-adenine dinucleotide 
phosphate; SOD-superoxide dismutase;  CAT-
catalase; glutathione reductase (GR) and glutathione 
peroxidase (GSHPx) 
 
MATERIALS AND METHODS 
 
Plant material  
Fresh fruits of Ferocactus latispinus (FL)  and  
Ferocactus histrix (FH)  were collected at Hidalgo 
State Mexico. A voucher specimen (No. 6922 and 
6923 respectively) was deposited in the Herbarium of 
the Escuela Nacional de Ciencias Biologicas, IPN for 
further reference. 
 
Animals 
Study was conducted in male Wistar strain albino rats 
of the same age and weight (180-225 g). Before and 
during  experiment, animals were fed with normal 
laboratory diet and water ad libitium. Procedures 
involving animals and their care conformed to the 
international guidelines Principles of Laboratory 
Animals Care. 
 
Preparation of plant extracts 
Fresh mature fruits of Ferocactus latispinus (FL)  and  
Ferocactus histrix (FH)  were cut into small pieces 
and each were dried in the laboratory at room 
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temperature and  powdered in a mechanical grinder. 
To prepare the extract, 300 g of the plant powder  was 
extracted with 1 l of hexane, chloroform and methanol 
consecutively using a soxhlet apparatus.  The residue 
was removed by filtration and the filtrate was 
evaporated to dryness at 40-50 
o
C under reduced 
pressure in a rotary evaporator  for complete removal 
of solvent. Aqueous suspension extract fruits were  
prepared using  2% (v/v) Tween-80 and used for oral 
administration. 
 
Acute toxicity studies 
Healthy adult Wistar strain of albino rats weighing 
between 180-230 g of either sex, they were orally fed 
with hexane, chloroform and methanol   extracts of FL  
and  FH  increasing dose levels of 1, 2 and  3 g/kg 
body weight. Animals were observed continuously for 
2 h for behavioral, neurological and autonomic 
profiles and after a period of 24 and 72 h for any 
lethality or death (Turner, 1965). 
 
Study on glucose-loaded animals (oral glucose 
tolerance test)  
After overnight fasting, an 0-min blood sample was 
taken from the diabetic control rat group and diabetic 
plant extract group. Rats of both  groups were loaded 
with glucose (2 g/kg, p.o.) 30 min after administration 
of the drugs or vehicle (for control). Blood samples 
were drawn by retro-orbital puncture. Blood glucose 
levels were measured at 30, 60, 120 and 180 min after 
glucose load to assess the effect of different doses of 
extract on blood glucose levels of the  animals. 
 
Experimental design 
Rats were fasted for 24 h before the induction of 
diabetes by STZ injection. Experimentally induced SD 
conditions were developed in a group of 
normoglycemic male Wistar strain albino rats by 
single intravenous injection of STZ at the dose of 65 
mg/kg body weight/rat in 0.5 ml of physiological 
saline. This single dose of STZ produced SD or type-I  
having fasting blood glucose level more than 250 
mg/dl after 24 h of STZ injection and this diabetic 
state was maintained throughout the experimental 
schedule: 
Normal rats:  treated with (FL)  and  (FH)  extract 100, 
200 or 300  mg/kg body weight.  
Severe diabetic: treated with  (FL)  and  (FH)  extract 
100, 200 or 300  mg/kg body weight. 
Animals of control group: received only 2% Tween-80 
Solution.  
All groups were treated with extract or vehicle for 28 
days. The fasting blood glucose was monitored (day 0, 
at 2, 4, 6, 8, 1 2 hr after extracts administration). Drug 
solutions or vehicle or standard such as tolbutamide 
(40 mg/kg body weight) or glibenclamide (0.5 mg/kg 
body weight) were administered orally by gastric 
intubations once daily at 9:00 am. On the 28th day, 
diabetic animals were sacrificed after blood collection, 
under ether anesthesia and the liver was removed. 
 
Measurement of glucose 
Rats were fasted for 18hr and blood samples were 
collected by puncture of retro-orbital plexus 
immediately with capillary tube under ether anesthesia 
into glass vials containing a small quantity of a 
mixture of potassium oxalate and sodium fluoride as 
an anticoagulant at 0 hr (before treatment) and after 
treatment.  Plasma blood glucose levels were 
determined by using GOD-POD method. This 
colorimetric method is based on the enzymatic 
reactions of invertase and glucose oxidase-peroxidase 
(GOD-POD)  (Sang-Eun et al.,  2007).
 
 
 
Serum lipid profile  
Triglycerides content and total cholesterol levels in 
serum were estimated by Diagnostic Reagent Kit 
(Genzyme Diagnostics). The level of lipid 
peroxidation was measured as a thiobarbituric acid 
reactive substance (TBARS).   
 
Determination of insulin  
Serum insulin was measured by a GLAZYME 
INSULIN-EIA TEST from diabetic rats. 300 mg/kg of 
extracts were orally administered to the rats for 28 
days, blood samples were taken for insulin 
determination. The level of insulin in serum was 
expressed in µIU/ml. 
 
Assay of glycogen content 
Rats of each group were orally administered 300 
mg/kg of extracts for 28 days, they were sacrificed  
and their livers and skeletal muscle were removed.  
100 mg of the liver tissues were homogenized in 5 
volumes of an ice-cold 30% (w/v) KOH solution and 
dissolved in a boiling water-bath (100 
o
C) for 30 min. 
The glycogen was precipitated with ethanol, washed, 
and resolubilized in distilled water. Thereafter, hepatic 
glycogen content was determined by the anthrone-
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reagent method (Seifer et al., 1950). The amount of 
blue compound generated by the reaction was assayed 
by a spectrophotometer at 620 nm. The glycogen  
content was expressed as mg/g wet tissue.  
 
Assay of G6Pase  and protein 
The hepatic G6Pase activity was assayed by the 
method of Trinder et al (1969).  In brief, the glucose-
6-phosphate in the liver extract was converted into 
glucose and inorganic phosphate. The inorganic 
phosphate liberated was determined with ammonium 
molybdate; ascorbic acid was used as the reducing 
agent. Excess molybdate was removed by the arsenite-
citrate reagent, so that it could no longer react with 
other phosphate esters or with inorganic phosphate 
formed by acid hydrolysis of the substrate. The 
amount of phosphate liberated per unit time, 
determined as blue phosphor-molybdenum complex 
was measured by spectrophotometer at 700 nm, it 
shows the glucose-6-phosphatase activity (Trinder et 
al., 1969).  Protein content of liver extract was 
quantified with Bradford reagent (Bradford, 1976). 
Glucose-6-phosphatase activity (mU) was expressed 
as mmol of phosphate released/min/ mg of protein. 
 
Assay of GK activities in liver 
GK (glucokinase) activity was measured using a 
method previously described  by Panserat et al., 
(2001). β-nicotinamide-adenine dinucleotide 
phosphate  (NADPH) generated by GK was measured 
using a spectrophotometer at 340 nm. GK activity was 
estimated by standard method, i.e. subtracting the rate 
of NADPH formation in presence of 0.5 mM glucose 
from that obtained in presence of 100 mM glucose. 
Protein concentration was quantified with Bradford 
reagent and one unit of enzyme activity (mU) was 
defined as mmol of substrate molecules converted by 1 
mg protein per minute. 
 
Measurements of SOD, CAT, GR and GSHPx 
The livers were homogenized with a homogenizer 
(Ultra Turrax T25, Rose Scientific Ltd., Edmonton, 
Canada) in 10 volumes of a 50 mM sodium phosphate 
buffer (PH 7.4) at 4 °C. Homogenates were 
centrifuged (Beckman, U.S.A.) at 15000Xg for 10 
min, and the supernatant obtained was used for the 
following antioxidant enzyme measurements. 
Antioxidant enzyme activities in the liver were 
assayed using commercial kits superoxide dismutase 
(SOD) assay kit Bioxytech  SOD-525 for SOD activity 
(Oxis International), catalase assay kit for catalase 
activity (Cayman Chemical),  glutathione peroxidase 
assay kit Bioxytech GPx-340 for GSHPx activity 
(Oxis International), and glutathione reductase assay 
kit Bioxytech GR-340 for GR activity, (Oxis 
International).  
 
Statistical analysis 
Data  are shown as mean ± S.E.M. and statistical 
analyses were performed by means of the Student's t-
test or by one-way ANOVA, followed by Dunnett´s 
multiple-comparison test (DMRT) using SPSS 
software when appropriate. The  statistical 
significance was assumed at p levels less than 0.05. 
Concentrations to produce 50% of the maximal 
responses (EC50) were calculated by a nonlinear curve 
fitting procedure using Sigma Plot version 8.0. 
 
Results  
Acute toxicity was tested up to a high concentration of 
3 g/kg. Extracts test did not show any mortality up to a 
dose of 3 g/kg body weight. Even at this high dose 
there was no gross behavioral changes, and did not 
exhibit any sign of toxicity. 
Table 1 shows changes in the levels of blood glucose 
in normal, diabetic control and experimental groups 
after oral administration of glucose (2 g/kg). Diabetic 
rats showed a significant increase in blood glucose at 
60 min and 90 min. In animals treated with chloroform 
extracts the blood glucose level were significantly 
(P<0.05) decreased after 60 min F. latispinus  and  F. 
histrix treated animals tend to bring values to near 
normal. 
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Table1 Effect of chloroform extracts of Ferocactus latispinus (FL)  and Ferocactus histrix  (FH) on oral glucose 
tolerance 
                                                                             Blood glucose levels (mg/dl) 
        Groups                          0 min                        30 min                     60 min                      90 min                    120 min 
   (300 mg/kg)     
Normal 
 
94.12 ±  0.99  182.43  ± 2.09   163.23 ±  1.13 132.89  ±  1.39 101.67±  1.24 
Diabetic control 
 
269.57 ±  6.34 345.36 ±  7.63 401.73 ±  4.48 372.48 ±  5.12  340.11 ±  5.13 
Diabetic + FL 
 
 248.30 ±  7.65 327.16 ± 7.59 * 302.53 ± 8.24*  164.29 ± 2.39* 143.72 ±  2.26*  
Diabetic + FH  
 
258.59 ±  6.52 347.09 ± 6.86* 326.46 ±  2.74* 202.62 ± 3.09 * 184.81 ±  2.87* 
Diabetic + 
Tolbutamide (40 
mg/kg) 
 
272.41 ± 4.83 342.37 ± 6.49* 302.81 ±  7.56* 162.51 ±  2.84* 127.76 ± 2.58* 
Values are mean ± S.E.M. for 6 animal each group. *p<0.05 when compared with  diabetic controls 
 
 
Table 2   Effect of chloroform extracts of  Ferocactus latispinus (FL)  and  Ferocactus histrix  (FH) on  fasting blood glucose level in 
no-diabetic rats 
     Group           Dose                                                          Blood glucose levels (mg/dl) at different hours 
                         (mg/kg)                0                       2                        4                          6                             8                             12           
 
Control 
 
 ---- 
 
105.19 ±  4.32 
 
 
104.13 ±  0.98 
(1.0) 
 
103.57 ±  0.73 
(1.5) 
 
103.29 ±  2.31 
(1.8) 
 
101.89 ±  0.68  
(3.1) 
 
102.13 ±  1.28  
(2.9) 
 
FL  
 
100 
 
200 
 
300 
 
107.28 ±  5.14 
 
98.87 ±  3.98  
 
98.17 ±  4.65 
93.75 ±  0.94 
(12.6) 
84.34± 2.12 * 
(14.7) 
80.56 ±  1.98* 
(18.0) 
90.16 ± 2.23 * 
(16) 
80.75±  1.54* 
(18) 
78.04±  2.14* 
(20.4) 
82.36 ± 1.67 * 
(23.1) 
65.84 ±  4.52* 
(33.4) 
56.71 ± 3.06* 
(42.2) 
85.26 ± 2.79* 
(20.5) 
69.48± 2.14 * 
(30) 
61.80±  2.83* 
(37.0) 
99.71 ±  1.46 * 
(7) 
87.32 ± 0.87 * 
(12) 
79.69 ±  0.34* 
(19) 
 
FH 100 
 
200 
 
300 
106.48 ±  5.03 
 
98.69 ±  4.87 
 
96.98 ±  3.86 
 
 
95.70 ±  1.27* 
(10.1) 
 85.53±  0.76*  
        (13.3)  
80.68 ± 1.05 * 
(17.0) 
92.51 ±  2.63* 
(13.1) 
82.36 ± 1.82*  
(16.5) 
79.48 ± 1.21*   
(18.0) 
85.67 ± 1.83 * 
(19.5) 
68.12 ± 4.21* 
(31) 
59.61 ± 4.27* 
(38.5) 
90.56 ± 2.56 * 
(15) 
72.52± 1.26* 
(26.5) 
63.59 ± 1.30 * 
(32.3) 
99.73 ± 1.35* 
(6.3) 
89.90 ±  0.87* 
(9.0) 
82.64±  1.92 * 
(14) 
 
Tolbutamide              40 99.47 ±  4.61 76.85 ± 1.85 * 
(22.6) 
59.34 ± 0.87* 
(40.3) 
56.23 ± 1.69 * 
(43.4) 
59.10 ±  1.08* 
(40.5) 
71.10 ± 1.04* 
(28.4) 
 
All values are expressed as Mean ± SEM, n=6; Values given in the parenthesis are percent blood glucose. Reduction; *P<0.05 when 
compared to control group animals; where the significance was performed by Oneway ANOVA followed by post hoc Dunnett´s test. 
 
 
 
Effect of different doses  of  chloroform  extracts of F. 
latispinus  and  F. histrix on blood glucose levels of  
 
normal, and  STZ induced diabetic rats  are shown in 
Tables 2 and 3 respectively. The maximum 
hypoglycemic activity on normal and diabetic mice, as 
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compared to the control group of animals (receiving an 
equal dose of Tween 80) was observed at 300 mg/kg 
doses.  The maximum percentage blood glucose 
reduction to normal mice at 6 h with 300 mg/kg doses 
of chloroform extracts of fruits of F. latispinus  and  F. 
histrix were 43.2 and 38.5% respectively.  
Tolbutamide 40 mg/kg dose produced 43.47% blood 
glucose reduction at 6 h in normal mice. The effect of  
several doses of chloroform  extracts of fruits of F. 
latispinus  and  F. histrix on fasting blood glucose 
levels in STZ induced diabetic mice  were assessed at 
different time intervals (Table 3). The percentage of 
blood glucose reduction of  chloroform extract of 
fruits FL and FH at dose of   300 mg/kg and a time of   
6 h were 43.0 and 39.0% respectively. Tolbutamide 
(40 mg/kg) produced 45.74% blood glucose reductions 
at 6 h in diabetic mice. Glibenclamide at doses of 0.5 
mg/kg exhibited  at 6 h  blood glucose reduction   of 
39.82%.  Chloroform extracts showed a marginal 
reduction in glucose level, which was not significant at 
dose level of 100 mg/kg. However, at 200 and 300 
mg/kg dose progressively reduced glucose level to a 
significant value (p<0.05). Among the tested extracts 
chloroform from fruits  was the most active. The 
results were comparable with of tolbutamide, which 
acts by stimulation of  insulin release  (Hermann et al.,  
1994). 
 
 
Table 3  Effect of  chloroform extracts of  Ferocactus latispinus (FL)  and  Ferocactus histrix  (FH) on  fasting blood glucose level  
in diabetic rats 
       Group            Dose                                                          Blood glucose levels (mg/dl) at different hours 
                          (mg/kg)          0                              2                        4                             6                             8                       12           
Diabetic 
control   
 ---- 341.14 ±  1.42  
 
350.21 ±  0.96 347.15  ±  1.93 358.91 ±  2.48 353.11 ±  1.15  
 
369.425±  4.46 
FL 
 
 
100 
 
200 
 
300 
 
348.49 ± 1.49 
 
360.31 ±  4.56  
 
363.28 ±  2.98 
320.28 ± 0.14* 
(8.0) 
317.43 ± 0.19* 
(12.0) 
306.61 ± 1.86* 
(16.0) 
316.26 ± 5.01* 
(9.2) 
299.52 ± 4.93* 
(17.0) 
241.20 ± 4.48* 
(33.6) 
309.30 ± 3.12* 
(11.2) 
242.27± 2.84 * 
(33.0) 
206.79 ± 1.99* 
(43.0) 
315.36± 0.97 * 
(10.0) 
258.32 ± 1.96* 
(28.3) 
220.71 ± 1.17* 
(39.2) 
319.45 ±  3.64* 
(8.3) 
314.62 ±  4.19* 
(13.0) 
299.08 ± 1.71 * 
(18.0) 
FH 
 
100 
 
200 
 
300 
350.62 ±  3.85 
 
349.28 ±  1.98 
 
353.17 ±  3.72 
328.34±  0.12* 
(6.3) 
314.51 ± 0.31* 
(10.0) 
301.47 ± 1.60* 
(15.0 ) 
323.75 ± 6.01*  
(8.0) 
303.06 ± 5.25* 
(13.2) 
281.44 ± 5.21* 
(20.3) 
315.13 ± 1.78* 
(10.1) 
241.53± 2.63 * 
(31) 
216.27 ± 3.50* 
(39.0) 
319.46± 2.48 * 
(9.0) 
252.39± 1.21 * 
(28.0) 
227.47± 1.45 * 
(35.6) 
326.53 ±  2.59* 
(7.0) 
312.64 ±  4.56* 
(10.5) 
299.16 ±  1.65* 
(15.2) 
Tolbutamide              40 348.43 ±  4.37 275.11 ± 2.67* 
     (21.0) 
213.23 ± 2.59*  
(39.0) 
185.6 ± 1.58 * 
       (46.0) 
209.50 ± 2.43* 
       (40.0) 
244.27± 3.46* 
(30.0) 
 
Gibenclamide 0.5 
 
336.62 ±  2.49 269. 51± 1.56* 
        (20.0)  
 
194.48 ± 2.77* 
(42.2) 
202.6 ± 2.11 * 
     (40.0) 
214.43± 1.21 * 
      (36.3) 
259. 22±  2.81* 
(23.0) 
 
All values are expressed as Mean ± SEM, n=6; Values given in the parenthesis are percent blood glucose. Reduction; *P<0.05 when 
compared to control group animals; where the significance was performed by Oneway ANOVA followed by post hoc Dunnett´s test. 
 
 
The effect of extracts on serum total cholesterol, total 
triglycerides levels are presented are Table 4. The 
lowering effect on serum total cholesterol level was 
found significant (p<0.05) with chloroform  extracts 
tested. Table 4 shows TBAR as index of lipid 
peroxidation in plasma, which  increased   in diabetic 
rats during the 28 days of the duration of the 
experiment. Chloroform extracts from fruits 
significantly lower these levels as compared to those 
in diabetic control.  
As shown in Table 5 glycogen content was increased 
by  FL and FH   as compared with diabetic group. The 
result in our studies shown that there is an increase in 
the glycogen content of liver and skeletal muscle of 
diabetic rats treated with extracts. 
 G6Pase activity was assessed in all groups (Table 5). 
Compared with diabetic control, the G6Pase effect was 
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decreased by FL and FH chloroform extracts. GK 
activity  was increased by  FL and FH   chloroform 
extracts. FL and FH extracts decreased G6Pase 
activity and increased glycogen and GK activity in 
liver, which indicates increased hepatic glucose uptake 
and decreased hepatic glucose release. So, both fruits 
of F. latispinus  and  F. histrix  enable hypoglycemic 
activity probably by reducing HGO via decreasing 
G6Pase activity and increasing GK activity. 
 
Table 4  Effect of chloroform extracts  fruits Ferocactus latispinus (FL)  and  Ferocactus histrix  (FH) on level of 
serum  triglyceride, total cholesterol, TBARS and glycogen content in skeletal muscle in STZ induced diabetic rats 
                                                                    Mean Concentration (mg/g) ± SEM  
   Treatment                             Triglycerides                Total cholesterol            Skeletal muscle glycogen             TBARS                                                                                                                                     
    (300mg/kg)                            (mg/dl)                          (mg/dl)                                                                            (mg/protein)                                             
Normal 91.32 ±  1.29 128.17 ± 2.49  12.57 ± 1.97   0.96 ± 2.01  
Diabetic Control 
 
178.15 ±  2.76
a
* 242.89 ± 3.21 
a
* 3.99 ± 2.17 
a
* 1.80 ± 3.47 
a
* 
FL 135.48 ±  1.65
b
**  165.43 ± 2.85 
b
** 9.71 ± 1.59 
b
** 1.23 ± 1.26 
b
** 
FH 143.31 ±  2.82
b
** 173.07 ± 1.87 
b
**       7.98 ± 2.63 
b
** 1.29 ± 1.68 
b
** 
Glibenclamide 
      (0.5)        
92.54 ± 1.13 
b
** 129.61 ±  1.76
b
** 12.11 ±  2.41
b
** 1.04 ±  2.20
b
** 
All values are expressed as Mean ± SEM, n=6 Values. 
a
when compared to normal  control  group, *P<0.01  
b
when  compared 
to diabetic control group, **P<0.01;  where the significance  was performed by Oneway  ANOVA followed by post hoc 
Dunnett´s test. 
 
 
Table 5 Effect of chloroform extracts  fruits Ferocactus latispinus (FL)  and  Ferocactus histrix  (FH) after 28 days 
treatment on   plasma insulin, glycogen levels, activities of  liver glucose 6-phosphatase and glucokinase  in  
STZ-induced SD 
Treatment                          Glycogen content            Glucose 6-                    Glucokinase                 Plasma insulin    
 (mg/kg )                                 (mg/kg )                   phosphatase                      activity (mU)                 (µU/ml)            
                                                                     activity (mU)                                                                       
Normal control 
 
16.21 ± 4.23 0.37 ± 3.21 3.19 ± 0.09 139.0 ±  3.86 
 
Diabetic Control 
 
11.10 ± 1.69
a
* 0.70 ± 2.37
a
* 1.16 ± 0.05
 a
* 54. 8 ± 1.84
a
* 
FL 
 
14.79 ± 5.31* 
 
0.47 ± 2.34
b
**  
 
2.23 ± 0.04
 b
** 
 
91.6± 1.91
b
** 
 
FH 
 
13.15 ± 4.62 * 
 
0.50 ± 6.01
b
** 
 
1.97 ± 0.06
 b
** 
 
86.7±  2.46
 b
** 
 
All values are expressed as Mean ± SEM, n=6; 
a
when compared to normal  control  group, *P<0.01  
b
when  compared to 
diabetic control group,  **P<0.01;  where the significance  was performed by Oneway    ANOVA  followed  by post hoc 
Dunnett´s test.  Extracts (300 mg/kg) were orally   administered  to the rats. 
 
 
Table 6 shows the result of antioxidant defense  
system in the liver (Table 6). In untreated STZ-
diabetic rat liver the SOD, GSH, GSHPx and CAT 
level were  significantly lower. Both extracts produced 
a gradual significant increase in SOD, GSH, GSHPx 
and CAT level  restoring them toward the normal 
levels. 
Serum insulin level was significantly decreased in 
streptozotocin-induced diabetic rats as compared to the 
control.  There was also a significant difference of this 
parameter between both groups (Table 5).  After 28 
days  of  extracts supplementation  to  SD rats,  there 
was a significant increase  in serum insulin level in 
respect to SD group. 
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Table 6 Effect of chloroform extracts  fruits Ferocactus latispinus (FL)  and  Ferocactus histrix  (FH)  
on antioxidant enzyme SOD, CAT, GSH and GSHPx   in SD rats 
    Treatment                               SOD                              CAT                                   GSHPx                           GSH                                                                
     (300/kg )                                                                   (U/mg protein)                                                                                      
Normal Control  
 
24.7 ± 2.03 194.1 ± 2.43 26.8 ±  0.37 3.6 ± 2.78 
Diabetic control 
 
13.6 ± 1.84
 a
* 155.3 ± 2.90
 a
* 17.9 ± 0.19
 a
* 2.4 ± 1.57
 a
*  
FL 
 
21.3 ± 1.32
 b
** 178.4 ± 4.71
 b
** 22.3 ± 0.96
 b
** 3.1 ± 3.39
 b
** 
FH 
 
18.9 ± 1.70
b
** 168.9 ± 3.82
 b
** 20.5 ± 1.45
 b
** 2.9 ± 2.28
 b
** 
All values are expressed as Mean ± SEM, n=6 values. 
a
when compared to normal  control  group, *P<0.01.  
b
when 
compared to diabetic control group,  **P<0.01;  where the  significance was performed  by  Oneway  ANOVA 
followed  by post hoc Dunnett´s test. 
 
Discussion 
Fruit of  F. latispinus  and  F. histrix used as a food, is 
claimed to be useful in treating diabetes. In this 
present investigation, the main focal points were the 
evaluation of the effectiveness  of fruit extracts of  F. 
latispinus  and  F. histrix in the  correction  of SD, 
where β cell degeneration is dramatic.  
Streptozotocin is known to destroy insulin-producing 
pancreatic β-cells. Therefore, STZ-treated rat model 
would appear to represent a good laboratory 
experimental diabetic state, with residual or remnant 
insulin production by pancreatic β-cells (Adewole and  
Ojewole, 2007). Acute treatment of the treated control 
group of rats with distilled water alone did not produce 
any significant change  (P > 0.05) in the blood glucose 
concentrations of either the fasted normal or the fasted 
STZ-treated diabetic rats. However, FL  and  FH  1ike 
glibenclamide, produced significant reductions in the 
blood glucose levels of STZ-treated diabetic rats. 
Provided that still remnant or residual insulin in the 
pancreatic β-cells, the hypoglycaemic and antidiabetic 
effects of FL  and  FH  would, therefore, appear to be 
most probably mediated via a mechanism that is 
similar to that of glibenclamide. The finding that FL  
and  FH  increased plasma insulin concentrations of 
the treated rats supports the hypothesis that the 
hypoglycaemic effect of the extract is likely to be 
mediated through a mechanism similar to that of 
glibenclamide (Chakravarthy et al.,  1982). The 
possibility also exists, however, that FL  and  FH  
could mimic and/or improve insulin action at the 
cellular level. The results of the oral glucose tolerance 
test study strongly suggest that FL  and  FH dose-
dependently reduces postprandial blood glucose levels. 
This postprandial hypoglycaemic effect of FL  and  
FH  could  be due to its ability to facilitate or enhance 
clearance of  postprandial blood glucose in rats. From 
glucose tolerance test it has been indicated that this 
extract did not execute the antihyperglycemic effect by 
modulating the absorption of  glucose in the intestine. 
 
The increase in oxygen free radicals in diabetes could 
be related to rise in blood glucose levels, leading to 
auto-oxidation to generate free radicals (Maritim et al., 
2003). Increased concentration of TBARS was 
observed in liver tissue during diabetes. In this study, 
hepatic TBAR decreased following FL  and  FH 
treatment, similar to glibenclamide-treated group. 
Lipid peroxide-mediated tissue damage has been 
observed in the development of diabetes mellitus. 
Elevated level of lipid peroxidation in tissues of STZ-
induced diabetic rats is one of the characteristic 
features of chronic diabetes (Pari and  Latha, 2005). In 
diabetes, it is thought that hypeinsulinemia increases 
the activity of the enzyme, fatty acyl coenzyme A 
oxidase, which initiates 13-oxidation of fatty acids, 
resulting in lipid peroxidation. The increase of lipid 
peroxidation levels causes functional impairment of 
membrane by decreasing membrane fluidity and 
through changing the activity of membrane-bound 
enzymes and receptors (Manonmani et al.,  2005).  
Lipid peroxidation will in tum result in elevated 
production of free radicals that are harmful to cells in 
the body.  
 
The present data also show that STZ-induced diabetes 
disturbs actions of hepatic antioxidant enzymes (SOD, 
GSH, GSHPx and CAT). The decreased activities of 
these enzymes in liver during diabetes mellitus may be 
due to the production of reactive oxygen free radicals 
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that can themselves reduce the activity of these 
enzymes (Kumar et al., 2006). These enzymes could 
destroy the peroxides and play a significant role in 
providing antioxidant defenses to an organism. In the 
enzymatic antioxidant defense system, SOD and CAT 
are the two important scavenging enzymes that 
remove superoxide radicals (O2
.
) and hydrogen 
peroxide, respectively, in vivo. GSH plays a main role 
in minimizing oxidative damage and is known to be 
involved in the elimination of low H2O2 
concentrations, whereas CAT is sensitive to higher 
concentrations of H2O2 (Noawaboot  et al., 2009). 
Decrease in SOD, CAT, GSH and GSHPx activities 
may be due to inadequacy of antioxidant defenses in 
combating reactive oxygen species (ROS) production. 
The administration of extracts improves impairments 
of SOD, GSH, GSHPx  and CAT activities in SD. 
These results suggest that extracts prevents oxidative 
stress, act as a suppressor against liver cell damage 
and inhibit the progression of liver dysfunction 
induced by chronic hyperglycemia (Sowmya and 
Rajyalakshmi, 1999). 
Furthermore, the atenuating effect of this extract on 
experimental SD has been confirmed here by the 
testing the  glucose-6-phosphatase activity in liver,  as 
well as the quantification of glycogen in liver and 
skeletal muscle, which are the important indicators of 
diabetes mellitus. These effects may be due to low 
activity of cholesterol biosynthesis enzymes and or 
low level of lipolysis which are under the control of 
insulin  (Boby and  Leelamma, 2003).  Also the 
possible mechanism of antihyperglycemic action of 
this extract appears to be both pancreatic and extra 
pancreatic, which have been supported here by the 
serum insulin assay in SD rats. The extra pancreatic 
effect of this extract has been focused here by the 
significant recovery of glucose-6-phosphatase activity 
in liver in SD rats. The extra pancreatic effect may be 
by the sensitization of insulin receptor in target organ 
or by inhibiting  insulinase activity in both liver and 
kidney.  
 
Conclusion 
In conclusion, F. latispinus  and  F. histrix fruit have 
effects on hyperlipidemia,  hypoinsulinemia.   Thus, 
this study provides supporting evidence for the 
therapeutic potential of fruit of F. latispinus  and  F. 
histrix that may also be helpful to prevent and/or delay 
the onset of diabetes. We found no toxic effects, 
therefore, F. latispinus  and  F. histrix can be 
considered as a safe food supplement with potential as 
an anti-diabetic agent; however the investigation of 
major active constituents is still in progress. 
      
     References 
Adewole SO. and  Ojewole JAO. 2007. Insulin-
induced immunohistochemical and 
morphological changes in pancreatic β-cells of 
streptozotocin-treated diabetic rats. Methods 
Find Exp Clin Pharmacol 29: 447 – 455. 
Andrade-Cetto A. and   Heinrich M.  2005. Mexican 
plants with hypoglycaemic effect used in the 
treatment of diabetes. J Ethnopharmacol. 99: 
325 - 348.  
Bradford M. 1976. A rapid and sensitive method for 
the quantitation of microgram quantities of 
protein  utilizing the principle of protein-dye 
binding. Anal. Biochem. 72: 248 - 254 
Boby
 
R.G. Leelamma S. 2003. Blackgram fiber 
(Phaseolus mungo): Mechanism of 
hypoglycemic action. Plant Foods Hum. Nutr. 
58: 7 - 13. 
Chakravarthy BK., Gupta S., Gode KD. 1982. 
Functional beta cell regeneration in the islets of  
pancreas in alloxan induced diabetic rats by (- )-
epicatechin. Life Sci 31: 2693 - 2697  
Coskun O, Kanter M, Korkmaz A. and Oter S. 2005. 
Quercetin, a flavonoid antioxidant, prevents and 
protects streptozotocin-induced oxidative stress 
and β-  cell damage in rat pancreas. Pharmacol 
Res 5: 117 - 123. 
Fridlyand LE. and Philipson LH. 2005. Oxidative 
reactive species in  cell injury: Mechanisms in 
diabetes mellitus and therapeutic approaches. 
Ann. NY. Acad. Sci.1066: 136 - 151. 
Hermann LS, Schersten B, Bitzen T, Kjellstrom F., 
Lindgarde F., Melandev., A. 1994. Therapeutic 
comparison of  metformin and sulfonylurea, 
alone and various mechanism. Diabetes care 17: 
1100 - 1109.  
Kumar G, Murugesan AG, Pandian MR. 2006. Effect 
of Helicteres isora bark extract on blood 
glucose and hepatic enzymes in experimental 
diabetes. Pharmazie 61: 353 - 355  
Manonmani G, Shavapriya V, Kalpana S, 
Govindasamy S. and Apparanantham T. 2005.  
Antioxidant activity of Cassia fistula  (Linn.) 
flowers in alloxan induced diabetic rats. J.  
Ethnopharmacol 97: 39 - 42.  
Perez – Gutierrez et al Efecto de Ferocactus latispinus y F. histrix sobre  diabetes inducida por estreptozotocina  
 
          Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas Vol.9 (6) 2010 | 
 
 
Maritim AC, Sanders RA, Watkins JB. 2003. 
Diabetes, oxidative stress, and antioxidant. A 
review. J Bioch Mol Toxicol. 7: 24 - 38. 
McCune LM and Johns T, 2002.Antioxidant activity 
in medicinal plants associated with the 
symptoms of diabetes mellitus used by the 
indigenous peoples of the  North American 
boreal forest. J. Ethnopharmacol. 82: 197 - 205. 
Noawaboot  J, Pannangpetch P, Kukongviriyapan V, 
Kongyingyoes B and Kukongviriyapan U. 2009. 
Antihyperglycemic, antioxidant and 
antiglycation activities of mulberry leaf extract 
in streptozotocin-induced chronic diabetic rats. 
Plant Foods Hum. Nutr.  64: 116 – 121.  
Panserat S, Capilla E and Gutierrez J. 2001. 
Glucokinase is highly induced and glucose-6-
phosphatase poorly repressed in liver of 
rainbow trout (Oncorhynchus mykiss) by a 
single meal   with glucose. Comp. Biochem. 
Physiol. B, 128: 275 - 283. 
Pari L and Latha M. 2005. Antidiabetic effect of 
Scoparia dulcis; effect on lipid peroxidation in 
streptozotocin diabetes. Gen Physiol Biophys. 
24: 13 - 26. 
Sang-Eun P, Mee-Hyun C, Jin Kyu L, Jong-Sang K, 
Jeong Hwan K, Dae Young K, and Cheon-Seok 
P. 2007. A New Colorimetric method for 
determining the isomerization activity of 
sucrose isomerase. Bioscience, Biotech Bioch 
71: 583 - 586. 
Seifer S, Dayton S and Novic B. 1950. The estimation 
of glycogen with the anthrone reagent Arch 
Biochem Biophys, 50: 191 - 200. 
Sowmya P and Rajyalakshmi P. 1999. 
Hypocholesterolemic effect of germinated,  
fenugreek seeds in human subjects. Plant Foods 
Hum. Nutr. 53: 359 - 365 
Trinder P. 1969. Determination of g1ucose in blood 
using glucose oxidase with an  altemative 
oxygen acceptor. Ann. Clin. Biochem. 6: 24 - 
31.  
Turner MA. 1965. Screening methods in 
Pharmacology .New York: Academic Press, 26 
- 27.  
Venkatesh  S, Reddy BM, Reddy GD, Mullangi R and 
Lakshman M. 2010. Antihyperglycemic and 
hypolipidemic effects of Helicteres isora roots 
in alloxan-induced diabetic rats: a possible 
mechanism of action. J. Nat. Med. 64: 295 - 304 
 
